Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma

Table 3 Comparison of ubiquitin carboxy-terminal hydrolase L1 and glial fibrillary acidic protein levels in patients with glioma recurrence and those without recurrence before and after surgery

Time	UCH-L1 (pg/mL)	GFAP (ng/L)
Recurrence group (n = 22)
Preoperative	120.44 ± 6.41	19.59 ± 0.57
3 d after surgery	88.01 ± 2.44	10.00 ± 0.46
t value	37.398	289.806
P value	< 0.001	< 0.001
Non-recurrence group (n = 69)
Preoperative	89.38 ± 11.83	15.76 ± 1.58
3 d after surgery	67.09 ± 9.60	6.74 ± 1.16
t value	78.571	172.100
P value	< 0.001	< 0.001
Preoperative comparison of the two groups
t value	11.749	11.118
P value	< 0.001	< 0.001
Comparison of the two groups at 3 d after surgery
t value	10.086	12.791
P value	< 0.001	< 0.001

UCH-L1: Ubiquitin carboxy-terminal hydrolase L1; GFAP: Glial fibrillary acidic protein.